| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $185.3M | -2.4% |
| R&D Expense | $10.8M | -0.6% |
| SG&A Expense | $50.4M | -14.0% |
| Operating Income | -$47.9M | -103.5% |
| Pre-tax Income | -$56.9M | -71.0% |
| Income Tax | $386K | -41.7% |
| Net Income | -$57.7M | -471.8% |
| EPS (Basic) | -$1.53 | -466.7% |
| EPS (Diluted) | -$1.53 | -466.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -78.1% |
| Accounts Receivable | $45.5M | -7.0% |
| Current Assets | $86.1M | -14.6% |
| Total Assets | $188.1M | -15.0% |
| Current Liabilities | $95.2M | -1.7% |
| Long-term Debt | $27.9M | — |
| Total Liabilities | $138.1M | +20.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | +9.3% |
| Capital Expenditures | $2.0M | +183.4% |
| Investing Cash Flow | -$14.1M | -107.9% |
| Financing Cash Flow | $21.6M | +114.0% |
| Free Cash Flow | -$20.7M | +3.1% |
| $49.4M |
| -52.9% |